Results: VRCI

Search articles by EPIC code

Verici Dx – was the “fundraise to… continue the accelerated progress” or to avert cash crunch ahoy?...

Previously writing on transplant platform company Verici Dx (VRCI), in March I concluded ‘if the cash is not soon needed, why place now? With the cash burn and a pre-fundraise market cap at even the current 36p share price of above £51 million, avoid’. With a “Commercial Team Appointments” announcement now following results, what do I think now?...


Verici Dx – “fundraise to… continue the accelerated progress”, or to avert cash crunch ahoy?...

Verici Dx (VRCI), a developer of clinical diagnostics for organ transplant, has announced a placing of “at least £10.0 million” at 35p per share, stating it “intends to use the net proceeds of the fundraise to… continue the accelerated progress the company has experienced to date”. So what of currently a 4% share price fall in response?...

Page 1 of 1 (4 articles)
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments